Home » Vivus Gets Good News From Diabetes Drug Test
Vivus Gets Good News From Diabetes Drug Test
Vivus’ Phase II study for Qnexa, used for treating cardiovascular complications that arise from Type 2 diabetes, produced positive results.
The study was a randomized, multicenter, double-blind, placebo-controlled prospective trial with subjects receiving the drug or placebo. A subset analysis of subjects with high cardiovascular risk factors showed significant improvement with the drug, according to the company.
Results included reductions in blood pressure, a 32 percent decrease of triglyceride levels and a 35 percent reduction in fasting plasma glucose from patients’ baseline levels.
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May